Across the cohort, there was no significant difference in the level of RBD-specific IgA detected in stool in healthy controls and COVID-19 patients (p=0.48, Mann-Whitney test; Fig. 5C), nor in the total amount of fecal IgA (p=0.76, Mann-Whitney test; Fig. S4C). This evidence concerns the gene CD79A and COVID-19.